Angiotensin 1/2 (2-7): Atomic Insights for RAS and Blood Pressure Research

Executive Summary: Angiotensin 1/2 (2-7) is a biologically active peptide fragment derived from the renin-angiotensin system (RAS), featuring the sequence ARG-VAL-TYR-ILE-HIS-PRO and a molecular weight of 783.92 Da [APExBIO]. This peptide is generated via enzymatic cleavage of angiotensin I and II and plays a direct role in blood pressure regulation by stimulating aldosterone release and promoting sodium retention (Oliveira et al., 2025). Angiotensin 1/2 (2-7) demonstrates robust solubility in water (≥46.6 mg/mL), ethanol (≥2.78 mg/mL), and DMSO (≥78.4 mg/mL), facilitating experimental versatility [APExBIO]. High-purity (99.80%) is confirmed by HPLC and MS, making it ideal for mechanistic and translational research (Adrenorphin.net). Recent studies implicate angiotensin fragments, including (2-7), in modulating SARS-CoV-2 spike protein interactions, underscoring their relevance in infectious disease models (Oliveira et al., 2025).

Biological Rationale

Angiotensin peptides are central to the renin-angiotensin system (RAS), a regulatory network critical for cardiovascular and renal function (Oliveira et al., 2025). Angiotensinogen is cleaved by renin in the kidney to generate angiotensin I (1–10). Angiotensin I is then converted by angiotensin-converting enzyme (ACE) into angiotensin II (1–8), which exerts vasoconstrictor and aldosterone-releasing effects [Fig. 1]. Angiotensin 1/2 (2-7) represents a truncated, yet bioactive, fragment produced by further enzymatic processing. This peptide retains key functional motifs responsible for receptor engagement and downstream signaling. It is particularly relevant in research focused on hypertension, aldosterone modulation, and cardiovascular disease models.

Mechanism of Action of Angiotensin 1/2 (2-7)

Angiotensin 1/2 (2-7) contains the amino acid sequence ARG-VAL-TYR-ILE-HIS-PRO. This sequence corresponds to residues 2 through 7 of the parent angiotensin I and II peptides [APExBIO]. Upon generation, this peptide fragment can interact with angiotensin II receptors (notably AT1R and AT2R), modulating vascular tone and sodium balance. The peptide stimulates aldosterone synthesis in the adrenal cortex, leading to increased sodium retention and water reabsorption in the distal nephron. These activities collectively contribute to the maintenance of systemic blood pressure (Oliveira et al., 2025).

Recent in vitro evidence also suggests that N-terminally truncated angiotensin peptides, including (2-7), can enhance binding of viral proteins (e.g., SARS-CoV-2 spike) to cellular receptors such as AXL, potentially affecting viral pathogenesis (Oliveira et al., 2025).

Evidence & Benchmarks

• Angiotensin 1/2 (2-7) is generated via enzymatic cleavage of angiotensin I or II, retaining bioactivity for RAS modulation (Oliveira et al., 2025).
• The peptide sequence ARG-VAL-TYR-ILE-HIS-PRO is sufficient for receptor interaction and aldosterone release stimulation (APExBIO).
• High-purity (>99.8% by HPLC/MS) is confirmed for APExBIO's A1050 product, reducing off-target effects and experimental variability (APExBIO).
• Solubility benchmarks: ≥2.78 mg/mL in ethanol, ≥46.6 mg/mL in water, ≥78.4 mg/mL in DMSO, at 20°C (APExBIO).
• N-terminal deletions to angiotensin (2-7) yield fragments with enhanced AXL binding compared to full-length peptides, supporting use in infectious disease research (Oliveira et al., 2025).

This article extends the mechanistic framework discussed in 'Angiotensin 1/2 (2-7): Precision Peptide for Blood Pressure Models' by providing new evidence on viral binding modulation (Oliveira et al., 2025), and complements 'Applied Insights: Angiotensin 1/2 (2-7) in RAS and Disease' with updated purity and solubility data.

Applications, Limits & Misconceptions

Angiotensin 1/2 (2-7) is extensively applied in hypertension research, cardiovascular disease modeling, and studies of the renin-angiotensin signaling pathway. Its defined sequence and high solubility make it suitable for in vitro mechanistic assays, receptor binding studies, and preclinical models evaluating aldosterone-driven sodium retention. The peptide is also valuable in infectious disease research, particularly for exploring SARS-CoV-2 spike protein interactions with non-classical receptors such as AXL (Oliveira et al., 2025). However, the peptide is not intended for diagnostic or therapeutic use and should be handled strictly as a research reagent.

Common Pitfalls or Misconceptions

• Angiotensin 1/2 (2-7) is not a direct therapeutic agent; it is for research only (APExBIO).
• The peptide's effects are context-dependent and may not fully recapitulate the actions of full-length angiotensin II or I in vivo.
• Improper storage (>–20°C or prolonged exposure in solution) can reduce peptide integrity and experimental reproducibility.
• Results from in vitro systems may not directly translate to complex in vivo models.
• Misinterpretation of peptide concentration or solvent compatibility can lead to assay artifacts—always verify solubility values and buffer compatibility.

Workflow Integration & Parameters

Angiotensin 1/2 (2-7) from APExBIO (SKU: A1050) is supplied as a solid, enabling flexible solution preparation. Recommended storage is –20°C in sealed, desiccated containers. For experimental use, dissolve in water (≥46.6 mg/mL), DMSO (≥78.4 mg/mL), or ethanol (≥2.78 mg/mL), as required. For short-term experiments, solutions should be prepared fresh or stored at 4°C for no more than 24–48 hours. Purity is validated by HPLC and MS, and each lot is documented with a certificate of analysis [APExBIO].

Integrate this peptide into RAS pathway assays, aldosterone quantification protocols, and receptor binding studies. For detailed methodological guidance and troubleshooting, see 'Precision Tools for Next-Generation Disease Models', which this article updates with the latest findings on viral receptor interactions and solubility parameters.

Conclusion & Outlook

Angiotensin 1/2 (2-7) is a rigorously characterized, high-purity peptide essential for dissecting RAS dynamics and blood pressure regulation mechanisms. Its robust solubility and validated bioactivity enable precise experimental modeling across cardiovascular and infectious disease research contexts. Emerging data on its role in modulating viral receptor interactions highlight new directions for translational research. For up-to-date product specifications and ordering, consult the Angiotensin 1/2 (2-7) product page from APExBIO.